| 1 |
33803310 | The Janus Kinase Inhibitor Ruxolitinib Prevents Terminal Shock in a Mouse Model of Arenavirus Hemorrhagic Fever. | 2021 Mar 9 |
1 |
| 2 |
33811972 | Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease. | 2021 Jun |
5 |
| 3 |
34367186 | Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition. | 2021 |
1 |
| 4 |
31015190 | Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis. | 2019 Jul 11 |
3 |
| 5 |
28405527 | JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer. | 2017 |
4 |
| 6 |
27546300 | Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity. | 2016 Oct |
1 |